Human BLMH PharmaGenie ELISA Kit (SBRS0307)

Bleomycin hydrolase (BLMH) is a cytoplasmic cysteine aminopeptidase best known for inactivating the antitumor antibiotic bleomycin, and the Assay Genie Human BLMH PharmaGenie ELISA Kit provides a quantitative immunoassay for measuring endogenous human BLMH protein. Validated for cell culture supernatant, plasma, and serum samples, the kit supports in vitro studies of chemotherapy resistance as well as translational research into the enzyme's emerging links to amyloid-beta processing in neurodegenerative disease. The microplate-based format supplies reagents sufficient for 96 assays, including pre-coated strips, a recombinant BLMH standard series, biotinylated detection antibody, streptavidin-HRP conjugate, wash buffer, substrate, and stop solution. A colorimetric readout is generated on a standard plate reader, allowing direct interpolation of unknown samples against the included standard curve. Researchers working on tumor cell sensitivity to bleomycin, aminopeptidase biology, or BLMH as a candidate biomarker will find the assay a focused tool for protein-level measurement across human sample matrices.